Read the Journal of Managed Care + Specialty Pharmacy (JMCP) May 2025 Issue
AMCP Letter to Congress on Final Opioid Conference Report
AMCP sends letter to Congressional Leadership asking for the inclusion of 42 CFR Part 2 provisions and Medicare Fraud Waste and Abuse protections in a final opioid conference report.
Related
AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
Retinal diseases in patients with diabetes pose signi cant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
